News from sorrento therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 25, 2014, 07:47 ET Sorrento Therapeutics Forms Subsidiary Ark Animal Therapeutics to Develop Animal Health Applications

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and...


Mar 11, 2014, 06:00 ET Sorrento Therapeutics Appoints Mark Durand to its Board of Directors

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and...


Mar 06, 2014, 06:00 ET Sorrento Therapeutics to Present at ROTH Capital Partners 26th Annual Growth Stock Conference

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated...


Mar 06, 2014, 05:50 ET Sorrento Therapeutics Announces Three Presentations and a Satellite Symposium on Cynviloq™ at the 31st Annual Miami Breast Cancer Conference

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated...


Mar 03, 2014, 06:00 ET Sorrento Therapeutics hires Mike Royal as Senior Vice President of Clinical Development

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and...


Feb 11, 2014, 08:00 ET Sorrento Therapeutics Announces Two Presentations on Cynviloq™ at the Beaujon International Conference on "Cutting Edge in Liver and Pancreatic Tumors"

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and...


Feb 10, 2014, 16:00 ET Sorrento Therapeutics Expands its Exclusive Rights to Cynviloq™ to Include Australia, Canada and Mexico

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and...


Feb 06, 2014, 08:00 ET Sorrento Therapeutics to Present at 16th Annual BIO CEO & Investor Conference

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and...


Feb 03, 2014, 06:00 ET Sorrento Therapeutics Welcomes Daniel Levitt as a Director to its Board

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and associated...


Jan 10, 2014, 12:50 ET Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento; www.sorrentotherapeutics.com) announced today that Dr. Henry Ji, President and Chief Executive...


Jan 09, 2014, 09:00 ET Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and...


Jan 08, 2014, 09:00 ET Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento; www.sorrentotherapeutics.com), a late-stage clinical oncology company developing new...


Dec 19, 2013, 19:10 ET Sorrento Therapeutics Completes Acquisition of Concortis Biosystems

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) announced today that it has completed its acquisition of Concortis Biosystems, Corp.,...